Combating Prescription Drug Abuse
Raising Awareness and Improving Outcomes in Our Community
Date of Taping: April 8, 2011
Activity Location: Hilton Garden Inn, Kitty Hawk, NC.
* This session is archived on the Internet for clinicians around the country to use.
Launch Date: June 7, 2011
Expiration Date: June 7, 2012
Target Audience: This activity is intended for physicians, physician assistants, pharmacists, nurses, dentists, and counselors with an interest in preventing and treating prescription drug abuse.
Lippincott Continuing Medical Education Institute, Inc., is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the Lippincott Continuing Medical Education Institute, Inc., and Dare Coalition Against Substance Abuse.
Lippincott CME Institute, Inc., designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Lippincott Continuing Medical Education Institute, Inc., is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This live program is designated for a maximum of 1.5 contact hours (0.15 CEUs). ACPE Universal Activity Number 0431-999-11-001-C04-P has been assigned to this program.
Lippincott Williams & Wilkins will award 1.5 contact hours for this continuing nursing education activity.
Lippincott Williams & Wilkins (LWW) is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749 for 1.5 contact hours, District of Columbia, and Florida #50-1223. Your certificate is valid in all states.
The ANCC's accreditation status of Lippincott Williams & Wilkins Department of Continuing Education refers only to its continuing nursing educational activities and does not imply Commission on Accreditation approval or endorsement of any commercial product.
This live activity is supported in part by educational grants from Abbott Pharmaceuticals, Endo, and Purdue Pharma.
In-kind contributors include Coastal Impressions, Dare County Public Relations, East Carolina Behavioral Health, Kellogg Supply Company, NC Aquarium at Manteo, Village Realty, Alison Williams and Doug Stoddart, Catherine Overstreet, Chris Baucom, Dennis Engelbart, Elizabeth Blanchard, Jenny Myatt, Jim MacDonald, Malcolm Fearing, Marie Holland, Pris Shea, Rodney Midgett, Trish Blackman, Peggy Saporito, and JoAnn Hummers. These contributions included small financial donations, assistance with participant recruitment, assistance with graphic design, assistance with identification of educational needs, loaning of equipment, donation of postage, and lodging for faculty.
Statement of Need
Prescription drug abuse is a national health crisis. The number of new prescription drug abusers in the US has increased 251% since 1992.1,2 Primary care physicians (PCPs) and their staffs are at the forefront of the daunting task of balancing effective pain management with the risk of addiction and have a responsibility to minimize abuse and diversion of controlled substances. However, although 30% of physicians believe they are very prepared to spot drug abuse, less than 1/3 of them carefully screen for it; more than 9 in 10 fail to detect substance abuse in adults and more than 4 of 10 in teens. In addition, 47% of PCPs report difficulty discussing substance abuse with their patients.3-5
Substance abuse is the #1 community-identified health priority for Dare County, NC. The need for educational interventions to combat this epidemic was summarized by a local clinician: "Working as a physician assistant in an urgent care/family medicine clinic, I feel particularly vulnerable to those seeking narcotics. To prescribe controlled substances appropriately, providers need to participate in relevant CME, but the last program offered at the Outer Banks was years ago. I was thrilled to learn that a CME conference about prescription medication misuse and abuse is being planned in our area. This will fill a huge void in our community."
Addressing Clinician Competencies
This activity will help clinicians address the following competencies:
Core Competencies adopted by the Institute of Medicine
• Provide patient-centered care
• Work in interdisciplinary teams
Core Competencies adopted by the Federation of State Medical Boards
• Interpersonal and communication skills
• Systems-based practice
• Compassionate and effective patient care
These activities will also help physicians comply with the FSMB's Model Policy for the Use of Controlled Substances for the Treatment of Pain, which recommends that physicians incorporate safeguards into their practices to minimize the potential for abuse and diversion of controlled substances.
Faculty Credentials and Disclosure Information
Each speaker and his/her spouse/life partner (if any) has nothing to disclose.
Harry Haroutunian, MD
Betty Ford Center
Rancho Mirage, CA
James Tracy, DDS, CADCII
Pain Management and Intervention Specialist
Rancho Mirage, CA
Penelope Ziegler, MD
VA Health Practitioner's Monitoring Program
LCMEI Staff and Planning Committee Members
All LCMEI staff members and planners in a position to control the content of this CME activity have disclosed that they and their spouse/life partners (if any) have no financial relationships with, or financial interests in, any commercial companies pertaining to this educational activity.
Lippincott CME Institute, Inc., did not have to resolve any conflicts of interest regarding this educational activity because no one disclosed relevant relationships.
Clinicians should ensure that all diagnostic and therapeutic modalities are prescribed and used appropriately, based on accepted standards of care. Use of any drugs, devices, and other techniques should be guided by approved labeling/full prescribing information, best available evidence, and professional judgment.
After participating in this activity, participants should be better able to:
- Relate the prescription drug abuse crisis to their own practice
- Evaluate strategies for preventing prescription drug abuse
Getting the Most out of the Activity
As you prepare to participate in this activity, please reflect on your practice and your patients, and identify clinical challenges you hope to have addressed.
While participating in the conference, identify ways you can use newly acquired knowledge, strategies, and skills to enhance patient outcomes and your own professional development.
Please take advantage of the numerous networking opportunities during the conference. And, join us on Facebook to participate in a community of practice to prevent prescription drug abuse and improve patient care: http://www.facebook.com/pages/CRAb-Combating-Prescription-Drug-Abuse/157750420920223
Method of Participation
To earn CME/CE credit, a participant must register for and attend the activity and complete the evaluation questionnaire. A certificate will be sent to documented participants within 4 to 6 weeks of participation. Send questions to or request further information regarding CME/CE credit from the Office of Continuing Education, Lippincott Continuing Medical Education Institute, Inc., Two Commerce Square, 2001 Market Street, 3rd floor, Philadelphia, PA 19103; fax: (215) 827-5614.
Educational Outcomes Analysis Plan
Lippincott CME Institute, Inc., will provide learners with an evaluation questionnaire that will allow them the means to assess the activity's quality, whether the goals of the activity were met, fairness and balance, and the effect on physician clinical practice behavior of the educational activity. A follow-up survey will be sent to participants a few months after the conference. Lippincott CME Institute, Inc., will compile and analyze the evaluation data, share the data with the conference planners, and utilize that data in the development of future CME activities.
1. Keller N. Prescription drug abuse "deadly and growing" epidemic. Coastland Times. July 11, 2010. 1A,11A.
2. Kraman P. Drug Abuse in America—Prescription Drug Diversion. Council of State Governments; Lexington, KY: 2004.
3. Fishman SM. Responsible Opioid Prescribing: A Physician's Guide. Dallas, TX; Federation of State Medical Boards. 2009.
4. O'Connor G. Doctors' role in the prescription drug crisis. Addiction Professional. July/August 2010. Available at: http://www.addictionpro.com/ME2/Segments/Publications/Print.asp?Module=Publ. Accessed August 16, 2010.
5. U.S. Preventive Services Task Force (USPSTF). Screening for Illicit Drug Use. Agency for Healthcare Research and Quality: Rockville, MD. Jan 7 2008.